Non-Small Cell Lung Cancer: The Impact of Ethnic Origin on Patients being Treated Second Line with Pemetrexed - an Observational Study

Grants and Contracts Details

StatusFinished
Effective start/end date8/8/0812/31/10

Funding

  • Eli Lilly and Company: $4,869.00